Delta 9 Cannabis Inc. (DN.TO)
Delta 9 Cannabis Inc.
1066 West Hastings Street
Suite 2600
Vancouver, BC V6E 3X1
Canada
https://www.delta9.ca
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 200
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. John William Arbuthnot IV | Co-Founder, CEO & Director | 180.81k | N/D | 1990 |
| Mr. John William Arbuthnot III | Co-Founder & Director | 180.81k | N/D | 1954 |
| Mr. James Lawson | CFO, Controller & Secretary | 134.53k | N/D | 1952 |
| Mr. Mark Jonker | Chief Operations Officer | N/D | N/D | N/D |
| Mr. Matthew Sodomsky | Chief Technology Officer | N/D | N/D | N/D |
| Mr. Marshall Posner | Chief Marketing Officer | N/D | N/D | N/D |
Descripción
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. The company was incorporated in 2001 and is based in Vancouver, Canada.
Gestión corporativa
La calificación ISS Governance QuickScore de Delta 9 Cannabis Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
